Particle.news
Download on the App Store

Amy Tapper Defends Mounjaro Use on GMB, Confronts Trolling After 8-Stone Loss

Her TV appearance highlights tension between a reported GP plan for ongoing medication versus NICE guidance limiting courses to two years.

Overview

  • The former Gogglebox star told Good Morning Britain she has faced severe online abuse since disclosing she used prescription weight-loss injections, saying the comments have taken a toll but she stands by her choice.
  • She said tirzepatide has quieted "food noise" and reduced cravings, describing her thoughts as "peaceful and quiet" and her day-to-day eating as easier to manage.
  • Tapper began the treatment in June 2024, reported losing 5lb in the first week and 4st in six months, and has dropped from a UK size 26 to size 18.
  • A regional report said her GP advised staying on the injections for life, a stance that contrasts with NICE guidance of a two‑year maximum course as NHS community prescribing expands in England.
  • She revealed plans to pursue skin-removal surgery to address loose skin following her rapid weight loss.